Human LATS1 Is a Mitotic Exit Network Kinase

Total Page:16

File Type:pdf, Size:1020Kb

Human LATS1 Is a Mitotic Exit Network Kinase Research Article Human LATS1 Is a Mitotic Exit Network Kinase John Bothos,1,2 Robyn L. Tuttle,1 Michelle Ottey,3 Francis C. Luca,3 and Thanos D. Halazonetis1,4 1The Wistar Institute; 2Program in Cell and Molecular Biology, Biomedical Graduate Studies; 3Department of Animal Biology, School of Veterinary Medicine; and 4Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Abstract cerevisiae, there are three members in the NDR family. Dbf2 and The kinase LATS/WARTS is a tumor suppressor protein its nearly identical and redundant Dbf20 kinase are key components of the mitotic exit network (MEN), a signaling pathway that conserved in evolution, but its function at the molecular level is not well understood. We report here that human LATS1 coordinates cyclin-dependent kinase (CDK) inactivation, sister interacts with MOB1A, a protein whose homologue in budding chromatid decondensation, and cytokinesis at the end of mitosis yeast associates with kinases involved in mitotic exit. This (13–15); on the other hand, Cbk1, the third member, promotes suggested that LATS1 may be a component of the previously polarized growth and activates daughter-specific gene transcription uncharacterized mitotic exit network in higher eukaryotes. after cytokinesis (16–19). In Schizosaccharomyces pombe, there Indeed, moderate overexpression of human LATS1 in cells are two members in the NDR family. Sid2, the orthologue of exposed to microtubule poisons facilitated mitotic exit, and Dbf2/Dbf20, functions in the septation initiation network (SIN), this activity required MOB1A. Reciprocally, small interfering which is analogous to the S. cerevisiae MEN (13–15); on the other RNA–mediated suppression of LATS1 or MOB1A prolonged hand, Orb6, like its orthologue Cbk1, is required for maintenance of cell polarity after completion of mitosis (20). telophase, but had no effect on the length of the earlier phases of mitosis. A role of LATS1 in mitotic exit may explain its The yeast NDR kinases require regulatory subunits for catalytic previously described abilities to induce G arrest and promote activity. In S. cerevisiae, there are two such subunits, Mob1 and 2 Mob2. Mob1 interacts with Dbf2 and Dbf20, whereas Mob2 cytokinesis. (Cancer Res 2005; 65(15): 6568-75) interacts with Cbk1. These interactions are conserved in S. pombe, such that S. pombe Mob1 and Mob2 interact with Sid2 and Orb6, Introduction respectively (18, 19, 21–25). LATS (large tumor suppressor, also known as WARTS) was The assignment of LATS1 to the NDR protein kinase family originally identified in a screen for genes whose inactivation leads to raises the possibility that LATS1 is an orthologue of yeast NDR overproliferation of cells in Drosophila (1, 2). Two homologues of kinases (either the Mob1- or the Mob2-interacting kinases). Indeed, LATS have been identified in mammals and are called LATS1/ we report here that in human cells, LATS1 interacts with MOB1A WARTS and LATS2/KPM (3–6). Inactivation of Lats1 in mice leads and has functional similarities to the yeast NDR kinases that to development of various tumors, including sarcomas and ovarian interact with Mob1 (S. cerevisiae Dbf2/Dbf20 and S. pombe Sid2). cancer (4). Further, promoter methylation, loss of heterozygosity, Thus, LATS1 is a component of the previously uncharacterized and missense mutations targeting LATS1 have been reported in mammalian MEN. human sarcomas and ovarian carcinomas (7, 8), suggesting that LATS functions as a tumor suppressor across evolution from Materials and Methods Drosophila to humans. At the molecular level, the function of LATS1 is not well Expression plasmids and cell transfections. The coding sequences of understood. LATS1 has been reported to inhibit the CDC2 kinase human NDR1, MOB1A, and MOB2 were amplified from expressed sequence tags by PCR and subcloned into a pCDNAzeo3.1 vector, which was modified by associating with CDC2 and displacing its cyclin subunit (3). to contain either hemagglutinin (HA) or FLAG tags within its polylinker. A More recently, LATS1 has been reported to inhibit the LIMK1 pCDNA3.1 plasmid expressing myc-tagged human LATS1 was provided by kinase again by directly interacting with LIMK1 (9). Inhibition of Dr. Wufan Tao (The Stem Cell Institute, University of Minnesota Medi- CDC2 may explain why LATS1 overexpression inhibits the cal School, Minneapolis, MN). These plasmids were transfected in U2OS transition from G2 to mitosis (3, 10, 11), whereas inhibition of osteosarcoma cells by calcium phosphate precipitation and their protein LIMK1 may explain the ability of LATS1 to promote cytokinesis products were analyzed 72 hours after transfection. For stable expression, because LIMK1 inhibits actin polymerization (9). the inserts encoding myc-tagged LATS1 and HA-tagged MOB1A were sub- Interestingly, LATS1 itself is a protein kinase, but its kinase cloned in the pIRESN2 vector. U2OS cells transfected with these vectors activity is not required for inhibition of LIMK1 and possibly of CDC2 or with a pIRESN2 vector that had no insert (neo control) were selected (3, 9). In turn, this suggests that LATS1 has functions that require its with 0.5 mg/mL G418 for 4 weeks. G418-resistant colonies were then pooled by trypsinization and propagated in tissue culture media containing 0.25 kinase activity and are independent of CDC2 and LIMK1. Based on mg/mL G418. its amino acid sequence, LATS1 has been assigned to the nuclear Small interfering RNA transfection. U2OS cells (150,000) were seeded Dbf2-related (NDR) family of protein kinases (12). In yeast, NDR in 60 mm tissue culture dishes and the following day were transfected with kinases are involved in cell cycle control. In Saccharomyces small interfering RNA (siRNA) specific for human MOB1A (AAUGCAGAAG- CAACUCUAGGA) or LATS1 (9) or luciferase (Dharmacon, Lafayette, CO) as a control. For analysis of cell cycle progression, the cells were synchronized 1 day later with a single thymidine block as described below. Requests for reprints: Thanos D. Halazonetis, The Wistar Institute, 3601 Spruce Cell cycle synchronization. The cells were synchronized by adding 1.3 Street, Philadelphia, PA 19104-4268. Phone: 215-898-3789; Fax: 215-573-9271; E-mail: [email protected]. mmol/L thymidine in the tissue culture media. After 20 hours, the cells were I2005 American Association for Cancer Research. washed twice with PBS and released into media containing 250 Amol/L Cancer Res 2005; 65: (15). August 1, 2005 6568 www.aacrjournals.org Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 2005 American Association for Cancer Research. Human Mitotic Exit Network thymidine and 250 Amol/L deoxycytidine. Where indicated, 8 hours after similarity to yeast Mob1; whereas MOB2 (also known as MMh) has release into S phase, the cells were exposed to 1 Amol/L nocodazole. high sequence similarity to yeast Mob2 (26, 27). Interactions Live cell videomicroscopy. Cells that had been cultured on 12 mm between LATS1 and human MOB proteins were assayed by autoclaved glass slides were synchronized and placed on the microscope transiently expressing in cells myc-tagged LATS1 together with stage 8 hours after release from the G -S block. The cells were observed 1 either HA-tagged MOB1A or HA-tagged MOB2 and performing using a phase contrast lens and maintained at 37jC using a stage heater (Bioptechs, Butler, PA). Images were acquired every 5 minutes using an coimmunoprecipitations. As controls, we also examined the ORCA ER digital camera (Hamamatsu, Hamamatsu City, Japan). interaction of MOB1A and MOB2 with human FLAG-tagged NDR1 Antibodies. A monoclonal antibody against human MOB1A was because NDR1 was recently reported to associate with human prepared using as antigen full-length MOB1A fused to the COOH terminus MOB2 (28). Myc-tagged LATS1 associated preferentially with HA- of glutathione S-transferase. The other antibodies were obtained commer- tagged MOB1A, whereas FLAG-tagged NDR1 associated preferen- cially: g-tubulin polyclonal (Sigma, St. Louis, MO), LATS1 polyclonal (Santa tially with HA-tagged MOB2 (Fig. 1A). Cruz Biotechnologies, Santa Cruz, CA), HA monoclonal (Covance, Princeton, The interaction between human LATS1 and MOB1A was further NJ), FLAG monoclonal (Sigma), 9E10-Myc monoclonal (Upstate, Charlottes- 10 examined by studying endogenous MOB1A. We prepared U2OS ville, VA), and histone H3 Ser phosphospecific polyclonal (Upstate). cells that stably express myc-tagged LATS1 (clones 1 and 2; Fig. 1B) Flow cytometry. For flow cytometry analysis, 1 Â 106 million cells were and used these cells (clone 1) to show that a monoclonal antibody trypsinized, washed once in PBS, and fixed in 70% ethanol at 4jC for at least 15 minutes. The cells were then washed in PBS, incubated in PBS that recognizes human MOB1A, but not a control antibody, supplemented with 0.25% Triton X-100 on ice for 5 minutes and then in coprecipitated myc-tagged LATS1 (Fig. 1C). We could not show the 200 AL 1% bovine serum albumin (BSA)/PBS containing 1 Ag anti–phospho- reciprocal interaction, because untagged human endogenous Ser10 histone H3 antibody at room temperature for 1 hour. After washing, MOB1A comigrates with immunoglobulin light chain (see Fig. 1A the cells were incubated in 200 AL 1% BSA/PBS containing 1 Ag Alexafluor showing HA-tagged MOB1A migrating just slightly slower than the 488–conjugated goat anti-rabbit antibody (Molecular Probes, Eugene, OR) immunoglobulin light chain). Finally, we could also detect an for 30 minutes
Recommended publications
  • Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling
    G C A T T A C G G C A T genes Review Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling Aoife A. Nolan 1, Nourhan K. Aboud 1, Walter Kolch 1,2,* and David Matallanas 1,* 1 Systems Biology Ireland, School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland; [email protected] (A.A.N.); [email protected] (N.K.A.) 2 Conway Institute of Biomolecular & Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland * Correspondence: [email protected] (W.K.); [email protected] (D.M.) Abstract: Oncogenic RAS (Rat sarcoma) mutations drive more than half of human cancers, and RAS inhibition is the holy grail of oncology. Thirty years of relentless efforts and harsh disappointments have taught us about the intricacies of oncogenic RAS signalling that allow us to now get a pharma- cological grip on this elusive protein. The inhibition of effector pathways, such as the RAF-MEK-ERK pathway, has largely proven disappointing. Thus far, most of these efforts were aimed at blocking the activation of ERK. Here, we discuss RAF-dependent pathways that are regulated through RAF functions independent of catalytic activity and their potential role as targets to block oncogenic RAS signalling. We focus on the now well documented roles of RAF kinase-independent functions in apoptosis, cell cycle progression and cell migration. Keywords: RAF kinase-independent; RAS; MST2; ASK; PLK; RHO-α; apoptosis; cell cycle; cancer therapy Citation: Nolan, A.A.; Aboud, N.K.; Kolch, W.; Matallanas, D. Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling.
    [Show full text]
  • Establishment and Genomic Characterization of a Sporadic Malignant Peripheral Nerve Sheath Tumor Cell Line Jody Fromm Longo1, Stephanie N
    www.nature.com/scientificreports OPEN Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line Jody Fromm Longo1, Stephanie N. Brosius3,5,7, Iya Znoyko1, Victoria A. Alers1, Dorea P. Jenkins1, Robert C. Wilson1,2, Andrew J. Carroll4, Daynna J. Wolf1, Kevin A. Roth6 & Steven L. Carroll1,2,3* Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived neoplasms that occur sporadically or in patients with neurofbromatosis type 1 (NF1). Preclinical research on sporadic MPNSTs has been limited as few cell lines exist. We generated and characterized a new sporadic MPNST cell line, 2XSB, which shares the molecular and genomic features of the parent tumor. These cells have a highly complex karyotype with extensive chromothripsis. 2XSB cells show robust invasive 3-dimensional and clonogenic culture capability and form solid tumors when xenografted into immunodefcient mice. High-density single nucleotide polymorphism array and whole exome sequencing analyses indicate that, unlike NF1-associated MPNSTs, 2XSB cells have intact, functional NF1 alleles with no evidence of mutations in genes encoding components of Polycomb Repressor Complex 2. However, mutations in other genes implicated in MPNST pathogenesis were identifed in 2XSB cells including homozygous deletion of CDKN2A and mutations in TP53 and PTEN. We also identifed mutations in genes not previously associated with MPNSTs but associated with the pathogenesis of other human cancers. These include DNMT1, NUMA1, NTRK1, PDE11A, CSMD3, LRP5 and ACTL9. This sporadic MPNST-derived cell line provides a useful tool for investigating the biology and potential treatment regimens for sporadic MPNSTs. Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive neoplasms derived from the Schwann cell lineage1,2.
    [Show full text]
  • Inhibition of Polo-Like Kinase 1 During the DNA Damage Response Is Mediated Through Loss of Aurora a Recruitment by Bora
    OPEN Oncogene (2017) 36, 1840–1848 www.nature.com/onc ORIGINAL ARTICLE Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora W Bruinsma1,2,4,5, M Aprelia1,2,5, I García-Santisteban1,3, J Kool2,YJXu2 and RH Medema1,2 When cells in G2 phase are challenged with DNA damage, several key mitotic regulators such as Cdk1/Cyclin B, Aurora A and Plk1 are inhibited to prevent entry into mitosis. Here we have studied how inhibition of Plk1 is established after DNA damage. Using a Förster resonance energy transfer (FRET)-based biosensor for Plk1 activity, we show that inhibition of Plk1 after DNA damage occurs with relatively slow kinetics and is entirely dependent on loss of Plk1-T210 phosphorylation. As T210 is phosphorylated by the kinase Aurora A in conjunction with its co-factor Bora, we investigated how they are affected by DNA damage. Interestingly, we find that the interaction between Bora and Plk1 remains intact during the early phases of the DNA damage response (DDR), whereas Plk1 activity is already inhibited at this stage. Expression of an Aurora A mutant that is refractory to inhibition by the DDR failed to prevent inhibition of Plk1 and loss of T210 phosphorylation, suggesting that inhibition of Plk1 may be established by perturbing recruitment of Aurora A by Bora. Indeed, expression of a fusion in which Aurora A was directly coupled to Bora prevented DNA damage-induced inhibition of Plk1 activity, as well as inhibition of T210 phosphorylation. Taken together, these data demonstrate that DNA damage affects the function of Aurora A at multiple levels: both by direct inhibition of Aurora A activity, as well as by perturbing the interaction with its co-activator Bora.
    [Show full text]
  • Photoreceptor Proliferation and Dysregulation of Cell Cycle Genes in Early Onset Inherited Retinal Degenerations
    University of Pennsylvania ScholarlyCommons Departmental Papers (Vet) School of Veterinary Medicine 3-11-2016 Photoreceptor Proliferation and Dysregulation of Cell Cycle Genes in Early Onset Inherited Retinal Degenerations Kristin L. Gardiner University of Pennsylvania Louise Downs University of Pennsylvania Agnes I. Berta-Antalics University of Pennsylvania Evelyn Santana University of Pennsylvania Gustavo D. Aguirre University of Pennsylvania, [email protected] See next page for additional authors Follow this and additional works at: https://repository.upenn.edu/vet_papers Part of the Veterinary Medicine Commons Recommended Citation Gardiner, K. L., Downs, L., Berta-Antalics, A. I., Santana, E., Aguirre, G. D., & Genini, S. (2016). Photoreceptor Proliferation and Dysregulation of Cell Cycle Genes in Early Onset Inherited Retinal Degenerations. BMC Genomics, 17 (221), http://dx.doi.org/10.1186/s12864-016-2477-9 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/vet_papers/152 For more information, please contact [email protected]. Photoreceptor Proliferation and Dysregulation of Cell Cycle Genes in Early Onset Inherited Retinal Degenerations Abstract Background Mitotic terminally differentiated photoreceptors (PRs) are observed in early retinal degeneration (erd), an inherited canine retinal disease driven by mutations in the NDR kinase STK38L (NDR2). Results We demonstrate that a similar proliferative response, but of lower magnitude, occurs in two other early onset disease models, X-linked progressive retinal atrophy 2 (xlpra2) and rod cone dysplasia 1 (rcd1). Proliferating cells are rod PRs, and not microglia or Müller cells. Expression of the cell cycle related genes RB1 and E2F1 as well as CDK2,4,6 was up-regulated, but changes were mutation-specific.
    [Show full text]
  • Comprehensive Identification of Proteins in Hodgkin Lymphoma
    Laboratory Investigation (2007) 87, 1113–1124 & 2007 USCAP, Inc All rights reserved 0023-6837/07 $30.00 Comprehensive identification of proteins in Hodgkin lymphoma-derived Reed–Sternberg cells by LC-MS/MS Jeremy C Wallentine1, Ki Kwon Kim1, Charles E Seiler III1, Cecily P Vaughn2, David K Crockett2, Sheryl R Tripp2, Kojo SJ Elenitoba-Johnson1,2 and Megan S Lim1,2 Mass spectrometry-based proteomics in conjunction with liquid chromatography and bioinformatics analysis provides a highly sensitive and high-throughput approach for the identification of proteins. Hodgkin lymphoma is a form of malignant lymphoma characterized by the proliferation of Reed–Sternberg cells and background reactive lymphocytes. Comprehensive analysis of proteins expressed and released by Reed–Sternberg cells would assist in the discovery of potential biomarkers and improve our understanding of its pathogenesis. The subcellular proteome of the three cellular compartments from L428 and KMH2 Hodgkin lymphoma-derived cell lines were fractionated, and analyzed by reverse- phase liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Additionally, proteins released by Hodgkin lymphoma-derived L428 cells were extracted from serum-free culture media and analyzed. Peptide spectra were analyzed using TurboSEQUESTs against the UniProt protein database (5.26.05; 188 712 entries). A subset of the identified proteins was validated by Western blot analysis, immunofluorescence microscopy and im- munohistochemistry. A total of 1945 proteins were identified with 785 from the cytosolic fraction, 305 from the membrane fraction, 441 from the nuclear fraction and 414 released proteins using a minimum of two peptide identi- fications per protein and an error rate of o5.0%.
    [Show full text]
  • PDF Hosted at the Radboud Repository of the Radboud University Nijmegen
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/85871 Please be advised that this information was generated on 2021-09-29 and may be subject to change. ISOFORMS IN MUSCLE AND BRAIN CELLS localization and function • ralph j.a. oude ophuis • 2011 9 789088 912344 > ISBN 978-90-8891234,-4 DMPK ISOFORMS IN MUSCLE AND BRAIN CELLS LOCALIZATION AND FUNCTION Voor het bijwonen van de openbare verdediging van het proefschrift van RALPH J.A. OUDE OPHUIS DMPK ISOFORMS IN MUSCLE AND BRAIN CELLS LOCALIZATION AND FUNCTION op vrijdag 1 april 2011 om 13:00u precies in de Aula van de Radboud Universiteit Nijmegen aan de Comeniuslaan 2 te Nijmegen Na afloop van de verdediging is er een receptie ter plaatse PARANIMFEN Susan Mulders [email protected] Rinske van de Vorstenbosch r.vandevorstenbosch(§) ncmls.ru.nl DMPK ISOFORMS IN MUSCLE AND BRAIN CELLS LOCALIZATION AND FUNCTION ISBN-13 978-90-8891234-4 ISBN-10 90-8891-234-3 Printed by Proefsohriftmaken.nl || Printyourthesis.com Published by Uitgeverij BOXPress, Oisterwijk DMPK ISOFORMS IN MUSCLE AND BRAIN CELLS LOCALIZATION AND FUNCTION Een wetenschappelijke proeve op het gebied van de Medische Wetenschappen Proefschrift ter verkrijging van de graad van doctor aan de Radboud Universiteit Nijmegen op gezag van de rector magnificus prof. mr. S.C.J.J. Kortmann, volgens besluit van het college van decanen in het openbaar te verdedigen op vrijdag 1 april 2011 om 13:00 uur precies door Raphaël Johannes Antonius Oude Ophuis geboren op 24 oktober 1978 te Sint-Oedenrode Promotor Prof.
    [Show full text]
  • Androgen Receptor
    RALTITREXED Dihydrofolate reductase BORTEZOMIB IsocitrateCannabinoid dehydrogenase CB1EPIRUBICIN receptor HYDROCHLORIDE [NADP] cytoplasmic VINCRISTINE SULFATE Hypoxia-inducible factor 1 alpha DOXORUBICINAtaxin-2 HYDROCHLORIDENIFENAZONEFOLIC ACID PYRIMETHAMINECellular tumor antigen p53 Muscleblind-likeThyroidVINBURNINEVINBLASTINETRIFLURIDINE protein stimulating 1 DEQUALINIUM SULFATEhormone receptor CHLORIDE Menin/Histone-lysine N-methyltransferasePHENELZINE MLLLANATOSIDE SULFATE C MELATONINDAUNORUBICINBETAMETHASONEGlucagon-like HYDROCHLORIDEEndonuclease peptide 4 1 receptor NICLOSAMIDEDIGITOXINIRINOTECAN HYDROCHLORIDE HYDRATE BISACODYL METHOTREXATEPaired boxAZITHROMYCIN protein Pax-8 ATPase family AAA domain-containing proteinLIPOIC 5 ACID, ALPHA Nuclear receptorCLADRIBINEDIGOXIN ROR-gammaTRIAMTERENE CARMUSTINEEndoplasmic reticulum-associatedFLUOROURACIL amyloid beta-peptide-binding protein OXYPHENBUTAZONEORLISTAT IDARUBICIN HYDROCHLORIDE 6-phospho-1-fructokinaseHeat shockSIMVASTATIN protein beta-1 TOPOTECAN HYDROCHLORIDE AZACITIDINEBloom syndromeNITAZOXANIDE protein Huntingtin Human immunodeficiency virus typeTIPRANAVIR 1 protease VitaminCOLCHICINE D receptorVITAMIN E FLOXURIDINE TAR DNA-binding protein 43 BROMOCRIPTINE MESYLATEPACLITAXEL CARFILZOMIBAnthrax lethalFlap factorendonucleasePrelamin-A/C 1 CYTARABINE Vasopressin V2 receptor AMITRIPTYLINEMicrotubule-associated HYDROCHLORIDERetinoidTRIMETHOPRIM proteinMothers X receptor tau against alpha decapentaplegic homolog 3 Histone-lysine N-methyltransferase-PODOFILOX H3 lysine-9OXYQUINOLINE
    [Show full text]
  • Activation of Diverse Signalling Pathways by Oncogenic PIK3CA Mutations
    ARTICLE Received 14 Feb 2014 | Accepted 12 Aug 2014 | Published 23 Sep 2014 DOI: 10.1038/ncomms5961 Activation of diverse signalling pathways by oncogenic PIK3CA mutations Xinyan Wu1, Santosh Renuse2,3, Nandini A. Sahasrabuddhe2,4, Muhammad Saddiq Zahari1, Raghothama Chaerkady1, Min-Sik Kim1, Raja S. Nirujogi2, Morassa Mohseni1, Praveen Kumar2,4, Rajesh Raju2, Jun Zhong1, Jian Yang5, Johnathan Neiswinger6, Jun-Seop Jeong6, Robert Newman6, Maureen A. Powers7, Babu Lal Somani2, Edward Gabrielson8, Saraswati Sukumar9, Vered Stearns9, Jiang Qian10, Heng Zhu6, Bert Vogelstein5, Ben Ho Park9 & Akhilesh Pandey1,8,9 The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing ‘driver’ oncogenic mutations of PIK3CA to dissect the signalling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K-enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signalling events and for discovering novel signalling molecules as readouts of pathway activation or potential therapeutic targets. 1 McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, 733 North Broadway, BRB 527, Baltimore, Maryland 21205, USA.
    [Show full text]
  • The Role of Zyxin and LIMD1 in Mitosis and Cancer
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-4-2019 The Role of Zyxin and LIMD1 in Mitosis and Cancer Jiuli Zhou University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Cancer Biology Commons, and the Cell Biology Commons Recommended Citation Zhou, Jiuli, "The Role of Zyxin and LIMD1 in Mitosis and Cancer" (2019). Theses & Dissertations. 353. https://digitalcommons.unmc.edu/etd/353 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE ROLE OF ZYXIN AND LIMD1 IN MITOSIS AND CANCER by Jiuli Zhou A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Pathology & Microbiology Graduate Program Under the Supervision of Professor Jixin Dong University of Nebraska Medical Center Omaha, Nebraska May, 2019 Supervisory Committee: Jennifer D. Black, Ph.D. Robert E. Lewis, Ph.D. Kaihong Su, Ph.D. i ACKNOWLEDGEMENTS Funding support: The China Scholarship Council; University of Nebraska Medical Center (UNMC) Graduate Studies Office Fellowship; National Cancer Institute/National Institutes of Health (NCI/NIH); Department of Defense; the COBRE Grant from the Nebraska Center for Cell Signaling/National Institute of General Medical Sciences (NIGMS/NIH). More important than the funding support, I would like to acknowledge the support and encouragement I received during my doctoral research.
    [Show full text]
  • SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma
    Published OnlineFirst February 27, 2019; DOI: 10.1158/1078-0432.CCR-17-3553 Translational Cancer Mechanisms and Therapy Clinical Cancer Research SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma Ilka Isfort1,2, Magdalene Cyra1,2, Sandra Elges2, Sareetha Kailayangiri3, Bianca Altvater3, Claudia Rossig3,4, Konrad Steinestel2,5, Inga Grunewald€ 1,2, Sebastian Huss2, Eva Eßeling6, Jan-Henrik Mikesch6, Susanne Hafner7, Thomas Simmet7, Agnieszka Wozniak8,9, Patrick Schoffski€ 8,9, Olle Larsson10, Eva Wardelmann2, Marcel Trautmann1,2, and Wolfgang Hartmann1,2 Abstract Purpose: Synovial sarcoma is a soft tissue malignancy Results: Asignificant subset of synovial sarcoma characterized by a reciprocal t(X;18) translocation. The chi- showed nuclear positivity for YAP/TAZ and their tran- meric SS18-SSX fusion protein acts as a transcriptional dysre- scriptional targets FOXM1 and PLK1. In synovial sarco- gulator representing the major driver of the disease; however, ma cells, RNAi-mediated knockdown of SS18-SSX led to the signaling pathways activated by SS18-SSX remain to be significant reduction of YAP/TAZ-TEAD transcriptional elucidated to define innovative therapeutic strategies. activity. Conversely, SS18-SSX overexpression in SCP-1 Experimental Design: Immunohistochemical evaluation cells induced aberrant YAP/TAZ-dependent signals, mech- of the Hippo signaling pathway effectors YAP/TAZ was per- anistically mediated by an IGF-II/IGF-IR signaling loop formed in a large cohort of synovial sarcoma tissue specimens. leading to dysregulation of the Hippo effectors LATS1 SS18-SSX dependency and biological function of the YAP/TAZ and MOB1. Modulation of YAP/TAZ-TEAD–mediated Hippo signaling cascade were analyzed in five synovial sarco- transcriptional activity by RNAi or verteporfintreatment ma cell lines and a mesenchymal stem cell model in vitro.
    [Show full text]
  • Inhibition of ERK 1/2 Kinases Prevents Tendon Matrix Breakdown Ulrich Blache1,2,3, Stefania L
    www.nature.com/scientificreports OPEN Inhibition of ERK 1/2 kinases prevents tendon matrix breakdown Ulrich Blache1,2,3, Stefania L. Wunderli1,2,3, Amro A. Hussien1,2, Tino Stauber1,2, Gabriel Flückiger1,2, Maja Bollhalder1,2, Barbara Niederöst1,2, Sandro F. Fucentese1 & Jess G. Snedeker1,2* Tendon extracellular matrix (ECM) mechanical unloading results in tissue degradation and breakdown, with niche-dependent cellular stress directing proteolytic degradation of tendon. Here, we show that the extracellular-signal regulated kinase (ERK) pathway is central in tendon degradation of load-deprived tissue explants. We show that ERK 1/2 are highly phosphorylated in mechanically unloaded tendon fascicles in a vascular niche-dependent manner. Pharmacological inhibition of ERK 1/2 abolishes the induction of ECM catabolic gene expression (MMPs) and fully prevents loss of mechanical properties. Moreover, ERK 1/2 inhibition in unloaded tendon fascicles suppresses features of pathological tissue remodeling such as collagen type 3 matrix switch and the induction of the pro-fbrotic cytokine interleukin 11. This work demonstrates ERK signaling as a central checkpoint to trigger tendon matrix degradation and remodeling using load-deprived tissue explants. Tendon is a musculoskeletal tissue that transmits muscle force to bone. To accomplish its biomechanical function, tendon tissues adopt a specialized extracellular matrix (ECM) structure1. Te load-bearing tendon compart- ment consists of highly aligned collagen-rich fascicles that are interspersed with tendon stromal cells. Tendon is a mechanosensitive tissue whereby physiological mechanical loading is vital for maintaining tendon archi- tecture and homeostasis2. Mechanical unloading of the tissue, for instance following tendon rupture or more localized micro trauma, leads to proteolytic breakdown of the tissue with severe deterioration of both structural and mechanical properties3–5.
    [Show full text]
  • PRODUCTS and SERVICES Target List
    PRODUCTS AND SERVICES Target list Kinase Products P.1-11 Kinase Products Biochemical Assays P.12 "QuickScout Screening Assist™ Kits" Kinase Protein Assay Kits P.13 "QuickScout Custom Profiling & Panel Profiling Series" Targets P.14 "QuickScout Custom Profiling Series" Preincubation Targets Cell-Based Assays P.15 NanoBRET™ TE Intracellular Kinase Cell-Based Assay Service Targets P.16 Tyrosine Kinase Ba/F3 Cell-Based Assay Service Targets P.17 Kinase HEK293 Cell-Based Assay Service ~ClariCELL™ ~ Targets P.18 Detection of Protein-Protein Interactions ~ProbeX™~ Stable Cell Lines Crystallization Services P.19 FastLane™ Structures ~Premium~ P.20-21 FastLane™ Structures ~Standard~ Kinase Products For details of products, please see "PRODUCTS AND SERVICES" on page 1~3. Tyrosine Kinases Note: Please contact us for availability or further information. Information may be changed without notice. Expression Protein Kinase Tag Carna Product Name Catalog No. Construct Sequence Accession Number Tag Location System HIS ABL(ABL1) 08-001 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) ABL(ABL1) BTN BTN-ABL(ABL1) 08-401-20N Full-length 2-1130 NP_005148.2 N-terminal DYKDDDDK Insect (sf21) ABL(ABL1) [E255K] HIS ABL(ABL1)[E255K] 08-094 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) HIS ABL(ABL1)[T315I] 08-093 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) ABL(ABL1) [T315I] BTN BTN-ABL(ABL1)[T315I] 08-493-20N Full-length 2-1130 NP_005148.2 N-terminal DYKDDDDK Insect (sf21) ACK(TNK2) GST ACK(TNK2) 08-196 Catalytic domain
    [Show full text]